Unknown

Dataset Information

0

The mitotic arrest deficient protein MAD2B interacts with the small GTPase RAN throughout the cell cycle.


ABSTRACT: BACKGROUND: Previously, we identified the mitotic arrest deficient protein MAD2B (MAD2L2) as a bona fide interactor of the renal cell carcinoma (RCC)-associated protein PRCC. In addition, we found that fusion of PRCC with the transcription factor TFE3 in t(X;1)(p11;q21)-positive RCCs results in an impairment of this interaction and, concomitantly, an abrogation of cell cycle progression. Although MAD2B is thought to inhibit the anaphase promoting complex (APC) by binding to CDC20 and/or CDH1(FZR1), its exact role in cell cycle control still remains to be established. METHODOLOGY/PRINCIPAL FINDINGS: Using a yeast two-hybrid interaction trap we identified the small GTPase RAN, a well-known cell cycle regulator, as a novel MAD2B binding protein. Endogenous interaction was established in mammalian cells via co-localization and co-immunoprecipitation of the respective proteins. The interaction domain of RAN could be assigned to a C-terminal moiety of 60 amino acids, whereas MAD2B had to be present in its full-length conformation. The MAD2B-RAN interaction was found to persist throughout the cell cycle. During mitosis, co-localization at the spindle was observed. CONCLUSIONS/SIGNIFICANCE: The small GTPase RAN is a novel MAD2B binding protein. This novel protein-protein interaction may play a role in (i) the control over the spindle checkpoint during mitosis and (ii) the regulation of nucleocytoplasmic trafficking during interphase.

SUBMITTER: Medendorp K 

PROVIDER: S-EPMC2737141 | biostudies-literature | 2009

REPOSITORIES: biostudies-literature

altmetric image

Publications

The mitotic arrest deficient protein MAD2B interacts with the small GTPase RAN throughout the cell cycle.

Medendorp Klaas K   van Groningen Jan J M JJ   Vreede Lilian L   Hetterschijt Lisette L   van den Hurk Wilhelmina H WH   de Bruijn Diederik R H DR   Brugmans Linda L   van Kessel Ad Geurts AG  

PloS one 20090915 9


<h4>Background</h4>Previously, we identified the mitotic arrest deficient protein MAD2B (MAD2L2) as a bona fide interactor of the renal cell carcinoma (RCC)-associated protein PRCC. In addition, we found that fusion of PRCC with the transcription factor TFE3 in t(X;1)(p11;q21)-positive RCCs results in an impairment of this interaction and, concomitantly, an abrogation of cell cycle progression. Although MAD2B is thought to inhibit the anaphase promoting complex (APC) by binding to CDC20 and/or C  ...[more]

Similar Datasets

| S-EPMC2994903 | biostudies-literature
| S-EPMC8469580 | biostudies-literature
| S-EPMC2755469 | biostudies-literature
| S-EPMC1567894 | biostudies-literature
| S-EPMC186374 | biostudies-literature
| S-EPMC6331428 | biostudies-literature
2024-03-02 | GSE259307 | GEO
| S-EPMC7157520 | biostudies-literature
| S-EPMC4403925 | biostudies-literature
| S-EPMC3989933 | biostudies-literature